Evidence map›Paper›PMID 26412228›Full record

ArticleHeart and vessels2016

Comparing mortality between coronary artery bypass grafting and percutaneous coronary intervention with drug-eluting stents in elderly with diabetes and multivessel coronary disease.

Ryo Naito, Katsumi Miyauchi, Hirokazu Konishi, Shuta Tsuboi, Manabu Ogita, Tomotaka Dohi, Kan Kajimoto, Takatoshi Kasai, Hiroshi Tamura, Shinya Okazaki and 4 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Heart and vessels, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. The impact of type 2 diabetes mellitus on prognosis in patients with non-ST elevation myocardial infarction.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2017
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Ryo NaitoDepartment of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Katsumi MiyauchiDepartment of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan. ktmmy@juntendo.ac.jp.
Hirokazu KonishiDepartment of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Shuta TsuboiDepartment of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Manabu OgitaDepartment of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Tomotaka DohiDepartment of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Kan KajimotoDepartment of Cardiovascular Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Takatoshi KasaiDepartment of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Hiroshi TamuraDepartment of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Shinya OkazakiDepartment of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Kikuo IsodaDepartment of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Taira YamamotoDepartment of Cardiovascular Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Atsushi AmanoDepartment of Cardiovascular Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Hiroyuki DaidaDepartment of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Juntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronary artery disease is a critical issue that requires physicians to consider appropriate treatment strategies, especially for elderly people who tend to have several comorbidities, including diabetes mellitus (DM) and multivessel disease (MVD). Several studies have been conducted comparing clinical outcomes between percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) in patients with DM and MVD. However, elderly people were excluded in those clinical studies. Therefore, there are no comparisons of clinical outcomes between CABG and PCI in elderly patients with DM and MVD. We compared all-cause mortality between PCI with drug-eluting stents (DES) and CABG in elderly patients with DM and MVD. A total of 483 (PCI; n = 256, CABG; n = 227) patients were analyzed. The median follow-up period was 1356 days (interquartile range of 810-1884). The all-cause mortality rate was not significantly different between CABG and PCI with DES groups. The CABG group had more patients with complex coronary lesions such as three-vessel disease or a left main trunk lesion. Older age, hemodialysis, and reduced LVEF were associated with increased long-term all-cause mortality in a multivariable Cox regression analysis. The rate of all-cause mortality was not significantly different between the PCI and CABG groups in elderly patients with DM and MVD in a single-center study.

Indexed as

Drug-Eluting StentsAgedAge FactorsCause of DeathChi-Square DistributionCoronary Artery BypassCoronary Artery DiseaseDatabases, FactualDiabetes MellitusDisease-Free SurvivalFemaleHumansKaplan-Meier EstimateMaleMultivariate AnalysisPercutaneous Coronary InterventionCoronary artery bypass graftDiabetes mellitusElderlyMultivessel diseasePercutaneous coronary intervention

Identifiers

PMID26412228
PMCPMC5010596
OpenAlexW2154210888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.